These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

125 related articles for article (PubMed ID: 8263501)

  • 21. Serological approaches to distinguish immune response to hepatitis A vaccine and natural infection.
    Robertson BH; Jia XY; Tian H; Margolis HS; Summers DF; Ehrenfeld E
    Vaccine; 1992; 10 Suppl 1():S106-9. PubMed ID: 1335637
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Single dose-inactivated hepatitis A vaccination schedule for susceptible youngsters.
    Lee SD; Chan CY; Yu MI; Wang YJ; Lo KJ; Safary A
    Am J Gastroenterol; 1996 Jul; 91(7):1360-2. PubMed ID: 8677995
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Single dose inactivated hepatitis A vaccine: rationale and clinical assessment of the safety and immunogenicity.
    Van Damme P; Matheï C; Thoelen S; Meheus A; Safary A; André FE
    J Med Virol; 1994 Dec; 44(4):435-41. PubMed ID: 7897376
    [TBL] [Abstract][Full Text] [Related]  

  • 24. The use of dried blood spots for assessing antibody response to hepatitis A virus after natural infection and vaccination.
    Melgaço JG; Pinto MA; Rocha AM; Freire M; Gaspar LP; Lima SM; Cruz OG; Vitral CL
    J Med Virol; 2011 Feb; 83(2):208-17. PubMed ID: 21181914
    [TBL] [Abstract][Full Text] [Related]  

  • 25. [The efficacy of the prevaccination detection of anti-HAV in hepatitis A vaccination programs].
    Navas E; Bayas JM; Bruguera M; Vidal J; Galí N; Taberner JL; Salleras L
    Med Clin (Barc); 1995 Jul; 105(5):168-71. PubMed ID: 7630228
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Anti-hepatitis A antibody titers after passive immunization with hepatitis A hyperimmune globulin.
    Poovorawan Y; Theamboonlers A; Vimolkej L; Cryz SJ
    Southeast Asian J Trop Med Public Health; 1995 Mar; 26(1):193-4. PubMed ID: 8525412
    [No Abstract]   [Full Text] [Related]  

  • 27. [A trial of a hepatitis A cultured inactivated vaccine on rhesus macaques].
    Shevtsova ZV; Flehmig B; Lapin BA; Esvandzhiia NCh; Krylova RI; Dzhelieva ZN; Tsyganok NM
    Zh Mikrobiol Epidemiol Immunobiol; 1995; (2):55-9. PubMed ID: 7653138
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Time course of hepatitis A antibody production after active, passive and active/passive immunisation: the results are highly dependent on the antibody test system used.
    Berger R; Just M; Althaus B
    J Virol Methods; 1993 Aug; 43(3):287-97. PubMed ID: 8408443
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Thermostability of an inactivated hepatitis A vaccine stored at 37 degrees C for one week.
    Wiedermann G; Ambrosch F; André FE; Delem A; D'Hondt E; Safary A
    J Med Virol; 1994 Dec; 44(4):442. PubMed ID: 7897377
    [No Abstract]   [Full Text] [Related]  

  • 30. Mathematical models for assessment of long-term persistence of antibodies after vaccination with two inactivated hepatitis A vaccines.
    Van Herck K; Beutels P; Van Damme P; Beutels M; Van den Dries J; Briantais P; Vidor E
    J Med Virol; 2000 Jan; 60(1):1-7. PubMed ID: 10568755
    [TBL] [Abstract][Full Text] [Related]  

  • 31. An inactivated hepatitis A viral vaccine of cell culture origin.
    Provost PJ; Hughes JV; Miller WJ; Giesa PA; Banker FS; Emini EA
    J Med Virol; 1986 May; 19(1):23-31. PubMed ID: 3009703
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Immunogenicity and safety in adults of hepatitis A virus vaccine administered as a single dose with a booster 6 months later.
    Briem H; Safary A
    J Med Virol; 1994 Dec; 44(4):443-5. PubMed ID: 7897378
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Detection of IgM against hepatitis A virus using tissue culture derived antigen.
    Chitambar SD; Arankalle VA; Banerjee K
    Indian J Med Res; 1991 Jan; 93():19-21. PubMed ID: 1850714
    [TBL] [Abstract][Full Text] [Related]  

  • 34. [Chronic hepatitis C and risk for hepatitis A infection].
    Chlabicz S; Grzeszczuk A
    Przegl Epidemiol; 2001; 55(3):281-6. PubMed ID: 11761835
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Clinical and immunological investigation of a new combined hepatitis A and hepatitis B vaccine.
    Ambrosch F; Wiedermann G; André FE; Delem A; Gregor H; Hofmann H; D'Hondt E; Kundi M; Wynen J; Kunz C
    J Med Virol; 1994 Dec; 44(4):452-6. PubMed ID: 7897380
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Testing for antibody to hepatitis A to decrease the cost of hepatitis A prophylaxis with immune globulin or hepatitis A vaccines.
    Bryan JP; Nelson M
    Arch Intern Med; 1994 Mar; 154(6):663-8. PubMed ID: 8129500
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Efficacy of an inactivated hepatitis A vaccine in pre- and postexposure conditions in marmosets.
    D'Hondt E; Purcell RH; Emerson SU; Wong DC; Shapiro M; Govindarajan S
    J Infect Dis; 1995 Mar; 171 Suppl 1():S40-3. PubMed ID: 7876647
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Decline of maternal hepatitis A virus antibody levels in infants.
    De Silvestri A; Avanzini MA; Terulla V; Zucca S; Polatti F; Belloni C
    Acta Paediatr; 2002; 91(8):882-4. PubMed ID: 12222709
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Hepatitis A among homosexual men and injection drug users: more evidence for vaccination.
    Villano SA; Nelson KE; Vlahov D; Purcell RH; Saah AJ; Thomas DL
    Clin Infect Dis; 1997 Sep; 25(3):726-8. PubMed ID: 9314468
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Hepatitis A vaccination by intracutaneous low dose administration: a less expensive alternative.
    Carlsson U; Brudin L; Eliasson I; Hansson BG
    Scand J Infect Dis; 1996; 28(5):435-8. PubMed ID: 8953668
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 7.